Cancer Pain

The solution to your pain lies at our fingertips.

Phase II clinical study examining CTT’s Calmare pain therapy medical device completed


The study examined the device’s effect on pain associated with CIPN that can produce sharp pains in the hands and feet of cancer patients who are undergoing chemotherapy. This debilitating pain affects about 30 to 40 percent of cancer patients treated with chemotherapy and typically develops into a classic stocking-and-glove pain that can last for many years. “Exploring ways to treat pain other than prescribing opioids such as morphine is key to our mission of improving the quality of life for cancer patients,” said Dr. Smith.


CTT’s Calmare Pain Therapy Treatment decreases pain associated with CIPN


Competitive Technologies, Inc. (NYSE Amex:CTT) today announced the issuance of an abstract from a study which has shown the successful treatment of patients suffering from pain associated with chemotherapy-induced peripheral neuropathy (CIPN) using CTT’s Calmare® Pain Therapy Treatment.


CTTC’s Calmare therapy effective against pain associated with chemotherapy-induced peripheral neuropathy


Calmare is being used to treat international patients in Italy, India, Greece, Bangladesh, and U.S. patients at clinics in Utah, Texas, Massachusetts, New York, Virginia, Florida, Connecticut and Rhode Island. In addition to treating pain associated with cancer and cancer treatments, Calmare Pain Therapy also successfully treats chronic neuropathic pain resulting from shingles, failed back surgery, phantom limb syndrome, sciatica, spinal stenosis and other maladies.


Clinical Studies


MC-5A for Chemotherapy Induced Peripheral Neuropathy


The purpose of this study is to determine if patients with painful CIPN will have a decrease in pain scores after treatment with the Calmare® MC-5A device.


Scrambler Therapy for Patients with Cancer Pain


January 2013, Park


MC-5A for Chemotherapy Induced Peripheral Neuropathy


NCT ID: NCT01261780

Sponsor: University of Wisconsin, Madison

Principal Investigator: Toby Campbell

Protocol IDs: OS10328


Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer


NCT ID: NCT01196442

Sponsor: Virginia Commonwealth University, Massey Cancer Center

Principal Investigator: Thomas J. Smith

Protocol IDs: MCC-13098, NCI-2010-01945


Scrambler Therapy in Treating Pain and Peripheral Neuropathy in Patients Previously Treated With Chemotherapy


NCT ID: NCT01347723

Sponsor: Mayo Clinic

Principal Investigator: Charles L. Loprinzi

Protocol IDs: MC10CC, NCI-2011-00339